3

PRIMARY DOCUMENT

Company: COLLEGIUM PHARMACEUTICAL, INC
Filed: May 6, 2015
Period of Report: May 6, 2015
Accession Number: 0001192482-15-000169

View Document ↗ View on SEC.gov ↗